Nerve News and Research

RSS

New pharmacological compounds block nerve cell damage in mouse models of MS

A newly characterized group of pharmacological compounds block both the inflammation and nerve cell damage seen in mouse models of multiple sclerosis, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published online this week in the journal Nature Neuroscience.

28 Feb 2015

Researchers one step closer to understanding development of glioblastoma

Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival.

26 Feb 2015

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child's life by age 10.

26 Feb 2015

Three Austrian men undergo bionic hand reconstruction

Three Austrian men have become the first in the world to undergo a new technique called “bionic reconstruction”, enabling them to use a robotic prosthetic hand controlled by their mind, according to new research published in The Lancet.

26 Feb 2015

Researchers generate mature, functional skeletal muscles using new approach

A team of researchers from Italy, Israel and the United Kingdom has succeeded in generating mature, functional skeletal muscles in mice using a new approach for tissue engineering. The scientists grew a leg muscle starting from engineered cells cultured in a dish to produce a graft.

25 Feb 2015

Study: Gene variant linked to increased risk of vincristine-induced peripheral neuropathy in children

Children with acute lymphoblastic leukemia who had a certain gene variant experienced a higher incidence and severity of peripheral neuropathy after receiving treatment with the cancer drug vincristine, according to a study in the February 24 issue of JAMA.

25 Feb 2015

Researchers identify first genetic variation linked to increased risk of peripheral neuropathy

Researchers have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used anti-cancer drug. Investigators also found evidence of how it may be possible to protect young leukemia patients without jeopardizing cures.

24 Feb 2015

Epigenome plays significant part in embryonic development

The early stages of embryonic development shape our cells and tissues for life. It is during this time that our newly formed cells are transformed into heart, skin, nerve or other cell types. Scientists are finding that this process is largely controlled not by the genome, but by the epigenome, chemical markers on DNA that tell cells when to turn genes on and off.

24 Feb 2015

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

Michael M. Halassa, MD, PhD, assistant professor, Departments of Psychiatry and Neuroscience and Physiology at NYU Langone Medical Center's Neuroscience Institute, has been selected as a winner of the 2015 Sloan Research Fellowship.

24 Feb 2015

Righttime Medical Care outlines common health concerns linked to cold temperatures

Righttime Medical Care, a leading urgent care provider, has been seeing an increase in injuries related to the record-breaking East coast cold weather and offers advice on keeping safe.

23 Feb 2015

Smartphones, tablets can do damage to overall health in unexpected ways

Despite the many benefits of having information at your fingertips, smartphones and tablets can do damage to your body and overall health in unexpected ways.

21 Feb 2015

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and Technology have revealed new understanding of the pathobiology behind a head and neck tumor that may someday lead to new methods of targeted drug therapy.

21 Feb 2015

Saluda Medical receives $10 million in Series B financing

Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain one step closer to reality.

20 Feb 2015

Study: Growth hormone can improve social impairment in patients with Phelan-McDermid syndrome

A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome, according to a pilot study conducted at the Icahn School of Medicine at Mount Sinai and published yesterday on Pub Med, a public database of biomedical topics maintained by the National Institutes of Health (study originally published in the December 12 issue of the journal Molecular Autism).

20 Feb 2015

New study finds that statins may not reduce risk for Parkinson's disease

The use of statins may not be associated with lowering risk for Parkinson's disease, according to a new study led by researchers at Penn State College of Medicine and National Institute of Environmental Health Sciences. The findings cast doubts on reports suggesting that the cholesterol-lowering medications may protect against this neurodegenerative brain disorder.

20 Feb 2015

IUPUI's Jason Meyer awarded $1.8 million NIH grant to explore how glaucoma develops in stem cells

Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, has received a National Institutes of Health grant to study how glaucoma develops in stem cells created from skin cells genetically predisposed to the disease.

20 Feb 2015

International study shows potential new therapy to treat patients with neuropathic pain

An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.

19 Feb 2015

New Danish study suggests that proactive labour induction practice can improve perinatal outcomes

A proactive labour induction practice once women are full term can improve perinatal outcomes suggests a new Danish study, published today (18 February) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

19 Feb 2015

Natalizumab drug helps scientists confirm how 'viral reservoirs' form in HIV patients

A drug used to treat patients with Crohn's disease and multiple sclerosis has helped scientists confirm how "viral reservoirs" form in patients living with HIV and also proven effective in animal trials at blocking the pathways to those reservoirs in the brain and gut, a team of researchers reported recently in the journal PLOS Pathogens.

19 Feb 2015

Recent clinical study offers hope for potential Parkinson's disease therapies

Researchers have long sought treatments that can slow the progression of Parkinson's disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopamine, which the dying nerve cells can no longer produce.

18 Feb 2015

Nerve News and Research

New pharmacological compounds block nerve cell damage in mouse models of MS

Researchers one step closer to understanding development of glioblastoma

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Three Austrian men undergo bionic hand reconstruction

Researchers generate mature, functional skeletal muscles using new approach

Study: Gene variant linked to increased risk of vincristine-induced peripheral neuropathy in children

Researchers identify first genetic variation linked to increased risk of peripheral neuropathy

Epigenome plays significant part in embryonic development

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

Righttime Medical Care outlines common health concerns linked to cold temperatures

Smartphones, tablets can do damage to overall health in unexpected ways

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Saluda Medical receives $10 million in Series B financing

Study: Growth hormone can improve social impairment in patients with Phelan-McDermid syndrome

New study finds that statins may not reduce risk for Parkinson's disease

IUPUI's Jason Meyer awarded $1.8 million NIH grant to explore how glaucoma develops in stem cells

International study shows potential new therapy to treat patients with neuropathic pain

New Danish study suggests that proactive labour induction practice can improve perinatal outcomes

Natalizumab drug helps scientists confirm how 'viral reservoirs' form in HIV patients

Recent clinical study offers hope for potential Parkinson's disease therapies

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News